Blog | Life Sciences

As of May 2021, manufacturers will need to create an annual summary of safety and clinical performance (SSCP) to remain in compliance with new EU regulations.

To avoid as many mistakes as possible, the time to begin paying attention to eCOA migration is at the very start of project planning with your eCOA vendor.

We all know there is a significant increase in data collected from wearable sensors, but what does that mean for eCOA? In our latest white paper, Mark Wade, Global Practice Leader for TransPerfect Life Sciences, examines the considerations of adopting these sensors as an addition to the typical clinical outcome assessment (COA) tools used routinely today.

What are the impacts on a study team? What are the considerations in selecting these modalities? How does consumer grade compare to industrial grade? Download the white paper now to learn about the use of wearables as eCOA tools.

In this whitepaper we re-explore the benefits and drawbacks of the traditional, paper-based outcomes assessment method, as well as the advantages of the emerging electronic clinical outcomes assessment (eCOA) solutions. With each having the potential to affect data quality, timelines, and overall trial cost, the choice between them is a much discussed topic.

Patients are, at last, gaining a voice in healthcare. Stakeholders have come to recognize that patients have valuable information to share about their experiences with diseases and medications that should influence policy and treatment decisions.

However you choose to carry out your clinical research processes, don’t forget to watch the traffic around you and keep your eyes on the road.

Not every copy in the TMF must be a certified copy. Trial Interactive answers the most frequently asked questions about certified copies for TMFs.

Each quality management system is made up of three pillars of technology: a document management system (DMS), a learning management system (LMS), and, once clinical trials begin, an electronic trial master file (eTMF).

Is all the talk about machine learning for clinical trials for real, or is it just hype?

What is CTMS? 

It was a challenging year in the life sciences industry, but there are numerous key takeaways from clinical trials and clinical research in 2020. 

After a paradigm shifting year for clinical research, what do industry experts anticipate for clinical trials in 2021?